TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml

7680692460011 CH-69246 H05AA04 07.99.0.

Reimbursement limitations:

TYMLOS

Le traitement nécessite une garantie de prise en charge des coûts par l’assureur maladie, après …

TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml
TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml
TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml
1 / 3
google

Details

Product number
6924601
CPT
-
Packaging group
1
Unit
Stück
Composition
abaloparatidum 2000 µg, natrii acetas trihydricus corresp. natrium 0.9 mg, acidum aceticum, phenolum, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

Tymlos 80 μg/40 μL, solution injectable en stylo prérempli
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/11/2024
Patient information leaflet
Français
28/11/2024
Patient information leaflet
Italien
28/11/2024
Professional SmPC
Allemand
28/11/2024
Professional SmPC
Français
28/11/2024
Professional SmPC
Italien
28/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2000.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 325.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
69246
Drug name
Tymlos, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
H05AA04
Authorization status
Z
Dispensation category
B
First authorization
07/03/2024
Authorization expiration date
06/03/2029
IT number
07.99.0.
Domain
Human medicine

Packaging details

Description (FR)
TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml
Description (DE)
TYMLOS Inj Lös 80 mcg/0.04ml Fertpen 0.04 ml
Market launch
07/03/2024
Narcotic (BTM)
No